STOCK TITAN

[SCHEDULE 13D/A] Aureus Greenway Holdings Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A discloses that a group of related entities and individuals led by American Ventures LLC, Series XVI AGH and Trajan Holdings LLC are reporting persons. Trajan directly owns 400,000 shares of AGH common stock, representing 2.74% of the 14,608,988 shares outstanding as of August 14, 2025. Series XVI AGH directly holds no common shares but holds large warrants (the "AGH Warrants") exercisable for a combined total of 88,800,791 shares across Common Warrants A, Common Warrants B and Pre-Funded Warrants, none exercisable within 60 days and each subject to a 4.99% (or 9.99% at holder election) beneficial ownership blocker. The reporting group purchased securities via private placements and a purchase agreement and states the holdings were acquired for investment purposes. Series XVI AGH reported recent warrant exercise and multiple sales of common shares in September 2025 that reduced the group’s beneficial ownership below 5%.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A rende noto che un gruppo di entità e individui collegati guidato da American Ventures LLC, Series XVI AGH e Trajan Holdings LLC sono persone riportanti. Trajan detiene direttamente 400.000 azioni ordinarie di AGH, pari al 2,74% delle 14.608.988 azioni in circolazione al 14 agosto 2025. Series XVI AGH non detiene direttamente azioni ordinarie ma possiede un ampio numero di warrant (gli "AGH Warrants") esercitabili per un totale combinato di 88.800.791 azioni attraverso i warrant comuni A, i warrant comuni B e i warrant pre‑finanziati; nessuno è esercitabile entro 60 giorni e ciascuno è soggetto a un blocco di proprietà beneficiaria del 4,99% (o 9,99% se il titolare lo sceglie). Il gruppo dichiara di aver acquistato i titoli tramite collocamenti privati e un accordo di acquisto e che le partecipazioni sono state acquisite a fini di investimento. Series XVI AGH ha riportato recentemente l’esercizio dei warrant e multiple vendite di azioni ordinarie nel settembre 2025, riducendo la partecipazione benefica del gruppo al di sotto del 5%.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A revela que un grupo de entidades y particulares relacionados, encabezado por American Ventures LLC, Series XVI AGH y Trajan Holdings LLC, son las personas reportantes. Trajan posee directamente 400,000 acciones de las acciones ordinarias de AGH, lo que representa el 2,74% de las 14.608.988 acciones en circulación a 14 de agosto de 2025. Series XVI AGH directamente no posee acciones comunes, pero sí posee una gran cantidad de warrants (los «AGH Warrants») susceptibles de ejercerse para un total combinado de 88.800.791 acciones a través de los Warrants Comunes A, Warrants Comunes B y Warrants Pre-Funded; ninguno es ejercitable dentro de 60 días y cada uno está sujeto a un bloqueo de propiedad beneficiosa del 4,99% (o 9,99% si el titular así lo elige). El grupo reportante adquirió valores mediante colocaciones privadas y un acuerdo de compra e indica que las participaciones fueron adquiridas con fines de inversión. Series XVI AGH informó recientemente ejercicios de warrants y múltiples ventas de acciones ordinarias en septiembre de 2025, lo que redujo la propiedad beneficiosa del grupo por debajo del 5%.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A는 American Ventures LLC, Series XVI AGH 및 Trajan Holdings LLC가 이끄는 연관된 법인 및 개인 그룹이 보고당사자임을 밝힙니다. Trajan은 AGH 보통주를 40만 주 직접 보유하고 있으며, 2025년 8월 14일 기준 발행주식 14,608,988주 중 2.74%를 차지합니다. Series XVI AGH는 직접적인 보통주를 보유하지 않지만, 대형 워런트를 보유하고 있으며(일명 'AGH 워런트') 공통 워런트 A, B 및 프리펀드 워런트를 합쳐 88,800,791주에 대해 행사 가능하며, 60일 이내에는 행사할 수 없고 각각은 4.99%(또는 보유자 선택 시 9.99%)의 유익한 소유권 차단의 적용을 받습니다. 보고 그룹은 비공개 배정 및 매매계약을 통해 증권을 매입했으며 투자 목적으로 보유하고 있다고 명시합니다. Series XVI AGH는 2025년 9월에 최근 워런트 행사 및 다수의 보통주 매도를 보고했고, 그 결과 그룹의 유익한 소유 지분이 5% 미만으로 감소했습니다.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A révèle qu’un groupe d’entités et de particuliers apparentés, dirigé par American Ventures LLC, Series XVI AGH et Trajan Holdings LLC, est une ou plusieurs personnes rapportant. Trajan détient directement 4 00 000 actions ordinaires d’AGH, représentant 2,74% des 14 608 988 actions en circulation au 14 août 2025. Series XVI AGH ne détient directement aucune action ordinaire mais détient d’importants warrants (les « AGH Warrants ») susceptibles d’être exercés pour un total combiné de 88 800 791 actions réparties entre Common Warrants A, Common Warrants B et Pre-Funded Warrants; aucun exercice dans les 60 jours et chacun soumis à un verrouillage de propriété bénéficiaire de 4,99% (ou 9,99% si le détenteur le décide). Le groupe rapporteur a acquis des valeurs via des placements privés et un accord d’achat et indique que les participations ont été acquises à des fins d’investissement. Series XVI AGH a signalé récemment l’exercice de warrants et plusieurs ventes d’actions ordinaires en septembre 2025, ce qui a réduit la propriété bénéficiaire du groupe à moins de 5%.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A offenbart, dass eine Gruppe verwandter Einheiten und Einzelpersonen unter Führung von American Ventures LLC, Series XVI AGH und Trajan Holdings LLC berichtende Personen ist. Trajan besitzt direkt 400.000 Aktien der AGH-Stammaktien, was 2,74% der zum 14. August 2025 ausstehenden 14.608.988 Aktien entspricht. Series XVI AGH hält direkt keine Stammaktien, besitzt aber umfangreiche Warrants (die „AGH Warrants“) mit dem Recht zum Erwerb von insgesamt 88.800.791 Aktien über Common Warrants A, Common Warrants B und Pre-Funded Warrants; keiner ist innerhalb von 60 Tagen ausübbar, und jeder unterliegt einem behördlichen Eigentumsbeschränkung von 4,99% (oder 9,99%, je nach Wahl des Inhabers). Die meldende Gruppe erwarb Wertpapiere über private Platzierungen und eine Kaufvereinbarung und erklärt, dass die Beteiligungen zu Anlagezwecken erworben wurden. Series XVI AGH berichtete kürzlich von der Ausübung von Warrants und mehreren Verkäufen von Stammaktien im September 2025, wodurch sich die beherrschende Beteiligung der Gruppe unter 5% verringert hat.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A يكشف أن مجموعة من الكيانات والأفراد ذوي الصلة يقودها American Ventures LLC، Series XVI AGH و Trajan Holdings LLC هم الأشخاص المبلغين. تمتلك Trajan مباشرة 400,000 سهم من أسهم AGH العادية، وتُمثل 2.74% من إجمالي 14,608,988 سهم قائم كما في 14 أغسطس 2025. Series XVI AGH لا تمتلك أسهم عادية بشكل مباشر لكنها تمتلك صفقات كبيرة من المنفذات (المشار إليها بـ "AGH Warrants") قابلة للممارسة لإجمالي قدره 88,800,791 سهم عبر Warrants Common A، Common Warrants B وPre-Funded Warrants؛ لا يمكن ممارسة أي منها خلال 60 يوماً وكل منها خاضع لحاجز ملكية مفيدة بنسبة 4.99% (أو 9.99% عند اختيار الحامل). ذكرت المجموعة المبلِّغة أنها اشترت الأوراق المالية عبر Placements خاصة واتفاقية شراء وتفيد بأن الحيازات تم شراؤها بغرض الاستثمار. وأفادت Series XVI AGH بتمرين المنفذات الأخيرة وببيع عدة أسهم عادية في سبتمبر 2025 مما قلّص الملكية المفيدة للمجموعة إلى ما دون 5%.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A 披露,由 American Ventures LLC、Series XVI AGH 及 Trajan Holdings LLC 领导的相关实体及个人集团为申报当事人。Trajan 直接持有 AGH 普通股 40 万股,占截至 2025 年 8 月 14 日在外流通的 14,608,988 股的 2.74%。Series XVI AGH 直接不持有普通股,但持有大量认股权证(“AGH Warrants”),可合计行使至 88,800,791 股,覆盖 Common Warrants A、Common Warrants B 与 Pre-Funded Warrants;没有一个在 60 天内可行使,且每个都受 4.99%(或持有者选择时为 9.99%)的受益所有权限制。申报集团通过私募发行和购买协议购买证券,并声明持有目的在于投资。Series XVI AGH 报告显示近期对认股权证的行使以及在 2025 年 9 月的多次普通股出售,导致集团的受益所有权降至 5% 以下。

Positive
  • Transparent disclosure of ownership, warrant positions, and recent transactions by the reporting group
  • Beneficial ownership is limited to 2.74% today, reducing immediate governance/control concerns
  • Warrants include 4.99%/9.99% blockers, which limit the ability to convert warrants into a larger ownership percentage immediately
Negative
  • Large contingent dilution potential from AGH Warrants totaling 88,800,791 shares if exercisable over time
  • Recent sales and warrant exercise in September 2025 indicate active trading that lowered ownership and could pressure share supply
  • No definitive agreements reported despite statements about potential strategic discussions, leaving uncertainty about future actions

Insights

TL;DR: Reporting group holds 2.74% of AGH and controls large warrant positions limited by 4.99%/9.99% blockers; recent trading reduced ownership below 5%.

The filing shows a modest equity stake (400,000 shares, 2.74%) combined with very large potential dilution from AGH Warrants totaling 88,800,791 shares if fully exercisable. Crucially, those warrants are currently not exercisable within 60 days and include contractual "blockers" that prevent the holder from increasing ownership above 4.99% (or 9.99% if elected), which limits immediate dilution risk and limits the reporting group’s ability to rapidly accumulate a controlling stake. The group’s recent activity in September 2025—exercise of Pre-Funded Warrants for 125,392 shares and multiple share sales—reduced beneficial ownership below 5%, which may lessen short-term governance influence. The filing frames the holdings as investment-oriented while retaining the possibility of engaging in strategic discussions with the issuer or third parties.

TL;DR: Group disclosure is detailed and shows limited present voting influence but significant contingent economic exposure via warrants constrained by ownership blockers.

The Schedule 13D/A provides clear mapping of relationships among Series XVI AGH, AV Management, AV IM, Dominari Holdings, Trajan and named individuals, and disclaims direct beneficial ownership beyond pecuniary interests. From a governance perspective, Trajan’s direct 2.74% stake and the group’s shared voting power do not confer substantial board influence today. However, the presence of very large warrant allocations creates contingent economic interest that could become material if exercisable and if contractual blockers are waived or modified. The filing notes potential discussions about strategic transactions but states no definitive agreements exist, underscoring that any governance or control changes remain speculative based on the document’s content.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A rende noto che un gruppo di entità e individui collegati guidato da American Ventures LLC, Series XVI AGH e Trajan Holdings LLC sono persone riportanti. Trajan detiene direttamente 400.000 azioni ordinarie di AGH, pari al 2,74% delle 14.608.988 azioni in circolazione al 14 agosto 2025. Series XVI AGH non detiene direttamente azioni ordinarie ma possiede un ampio numero di warrant (gli "AGH Warrants") esercitabili per un totale combinato di 88.800.791 azioni attraverso i warrant comuni A, i warrant comuni B e i warrant pre‑finanziati; nessuno è esercitabile entro 60 giorni e ciascuno è soggetto a un blocco di proprietà beneficiaria del 4,99% (o 9,99% se il titolare lo sceglie). Il gruppo dichiara di aver acquistato i titoli tramite collocamenti privati e un accordo di acquisto e che le partecipazioni sono state acquisite a fini di investimento. Series XVI AGH ha riportato recentemente l’esercizio dei warrant e multiple vendite di azioni ordinarie nel settembre 2025, riducendo la partecipazione benefica del gruppo al di sotto del 5%.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A revela que un grupo de entidades y particulares relacionados, encabezado por American Ventures LLC, Series XVI AGH y Trajan Holdings LLC, son las personas reportantes. Trajan posee directamente 400,000 acciones de las acciones ordinarias de AGH, lo que representa el 2,74% de las 14.608.988 acciones en circulación a 14 de agosto de 2025. Series XVI AGH directamente no posee acciones comunes, pero sí posee una gran cantidad de warrants (los «AGH Warrants») susceptibles de ejercerse para un total combinado de 88.800.791 acciones a través de los Warrants Comunes A, Warrants Comunes B y Warrants Pre-Funded; ninguno es ejercitable dentro de 60 días y cada uno está sujeto a un bloqueo de propiedad beneficiosa del 4,99% (o 9,99% si el titular así lo elige). El grupo reportante adquirió valores mediante colocaciones privadas y un acuerdo de compra e indica que las participaciones fueron adquiridas con fines de inversión. Series XVI AGH informó recientemente ejercicios de warrants y múltiples ventas de acciones ordinarias en septiembre de 2025, lo que redujo la propiedad beneficiosa del grupo por debajo del 5%.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A는 American Ventures LLC, Series XVI AGH 및 Trajan Holdings LLC가 이끄는 연관된 법인 및 개인 그룹이 보고당사자임을 밝힙니다. Trajan은 AGH 보통주를 40만 주 직접 보유하고 있으며, 2025년 8월 14일 기준 발행주식 14,608,988주 중 2.74%를 차지합니다. Series XVI AGH는 직접적인 보통주를 보유하지 않지만, 대형 워런트를 보유하고 있으며(일명 'AGH 워런트') 공통 워런트 A, B 및 프리펀드 워런트를 합쳐 88,800,791주에 대해 행사 가능하며, 60일 이내에는 행사할 수 없고 각각은 4.99%(또는 보유자 선택 시 9.99%)의 유익한 소유권 차단의 적용을 받습니다. 보고 그룹은 비공개 배정 및 매매계약을 통해 증권을 매입했으며 투자 목적으로 보유하고 있다고 명시합니다. Series XVI AGH는 2025년 9월에 최근 워런트 행사 및 다수의 보통주 매도를 보고했고, 그 결과 그룹의 유익한 소유 지분이 5% 미만으로 감소했습니다.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A révèle qu’un groupe d’entités et de particuliers apparentés, dirigé par American Ventures LLC, Series XVI AGH et Trajan Holdings LLC, est une ou plusieurs personnes rapportant. Trajan détient directement 4 00 000 actions ordinaires d’AGH, représentant 2,74% des 14 608 988 actions en circulation au 14 août 2025. Series XVI AGH ne détient directement aucune action ordinaire mais détient d’importants warrants (les « AGH Warrants ») susceptibles d’être exercés pour un total combiné de 88 800 791 actions réparties entre Common Warrants A, Common Warrants B et Pre-Funded Warrants; aucun exercice dans les 60 jours et chacun soumis à un verrouillage de propriété bénéficiaire de 4,99% (ou 9,99% si le détenteur le décide). Le groupe rapporteur a acquis des valeurs via des placements privés et un accord d’achat et indique que les participations ont été acquises à des fins d’investissement. Series XVI AGH a signalé récemment l’exercice de warrants et plusieurs ventes d’actions ordinaires en septembre 2025, ce qui a réduit la propriété bénéficiaire du groupe à moins de 5%.

Aureus Greenway Holdings Inc. (AGH) Schedule 13D/A offenbart, dass eine Gruppe verwandter Einheiten und Einzelpersonen unter Führung von American Ventures LLC, Series XVI AGH und Trajan Holdings LLC berichtende Personen ist. Trajan besitzt direkt 400.000 Aktien der AGH-Stammaktien, was 2,74% der zum 14. August 2025 ausstehenden 14.608.988 Aktien entspricht. Series XVI AGH hält direkt keine Stammaktien, besitzt aber umfangreiche Warrants (die „AGH Warrants“) mit dem Recht zum Erwerb von insgesamt 88.800.791 Aktien über Common Warrants A, Common Warrants B und Pre-Funded Warrants; keiner ist innerhalb von 60 Tagen ausübbar, und jeder unterliegt einem behördlichen Eigentumsbeschränkung von 4,99% (oder 9,99%, je nach Wahl des Inhabers). Die meldende Gruppe erwarb Wertpapiere über private Platzierungen und eine Kaufvereinbarung und erklärt, dass die Beteiligungen zu Anlagezwecken erworben wurden. Series XVI AGH berichtete kürzlich von der Ausübung von Warrants und mehreren Verkäufen von Stammaktien im September 2025, wodurch sich die beherrschende Beteiligung der Gruppe unter 5% verringert hat.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares represented by the amount in Rows 8, 10 and 11 includes (i) 0 shares of the Issuer's common stock owned by American Ventures LLC, Series XVI AGH ("Series XVI AGH") and (ii) 400,000 shares of the Issuer's common stock owned by Trajan Holdings LLC ("Trajan"). Series XVI AGH holds such shares and the AGH Warrants, discussed below, directly. Series XVI AGH owns no shares of the Issuer that are held by Trajan, directly or indirectly, and disclaims beneficial ownership interest in such shares. The number of shares represented by the amount in Rows 8, 10 and 11 excludes (i) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants A ("Common Warrants A"), (ii) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants B ("Common Warrants B"), and (iii) 29,030,677 shares of common stock that may be purchased by exercising the Issuer's Pre-Funded Common Stock Purchase Warrants ("Pre-Funded Warrants"), none of which are currently exercisable within 60 days (collectively, the "AGH Warrants"). However, pursuant to the warrant agreements relating to the AGH Warrants, the AGH Warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein Series XVI AGH may not exercise its AGH Warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XVI AGH together with its affiliates, and any other persons acting as a group together with Series XVI AGH or any of the Series XVI AGH's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XVI AGH, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of calculating the blockers, the number of shares of common stock beneficially owned by Series XVI AGH and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the AGH Warrants with respect to which such determination is being made, but will exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such warrant beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker pursuant to Rule 13d-3(d)(1)(i). The percent of class represented by the amount in Row 13 is based on 14,608,988 shares of the Issuer's common stock issued and outstanding as of August 14, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on August 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares represented by the amount in Rows 8, 10 and 11 includes (i) 0 shares of the Issuer's common stock owned by American Ventures LLC, Series XVI AGH ("Series XVI AGH") and (ii) 400,000 shares of the Issuer's common stock owned by Trajan Holdings LLC ("Trajan"). Series XVI AGH holds such shares and the AGH Warrants, discussed below, directly. Series XVI AGH owns no shares of the Issuer that are held by Trajan, directly or indirectly, and disclaims beneficial ownership interest in such shares. American Ventures Management LLC is the manager of Series XVI AGH and does not hold any shares or AGH Warrants directly. The number of shares represented by the amount in Rows 8, 10 and 11 excludes (i) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants A ("Common Warrants A"), (ii) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants B ("Common Warrants B"), and (iii) 29,030,677 shares of common stock that may be purchased by exercising the Issuer's Pre-Funded Common Stock Purchase Warrants ("Pre-Funded Warrants"), none of which are currently exercisable within 60 days (collectively, the "AGH Warrants"). However, pursuant to the warrant agreements relating to the AGH Warrants, the AGH Warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein Series XVI AGH may not exercise its AGH Warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XVI AGH together with its affiliates, and any other persons acting as a group together with Series XVI AGH or any of the Series XVI AGH's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XVI AGH, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of calculating the blockers, the number of shares of common stock beneficially owned by Series XVI AGH and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the AGH Warrants with respect to which such determination is being made, but will exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such warrant beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker pursuant to Rule 13d-3(d)(1)(i). The percent of class represented by the amount in Row 13 is based on 14,608,988 shares of the Issuer's common stock issued and outstanding as of August 14, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on August 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares represented by the amount in Rows 8, 10 and 11 includes (i) 0 shares of the Issuer's common stock owned by American Ventures LLC, Series XVI AGH ("Series XVI AGH") and (ii) 400,000 shares of the Issuer's common stock owned by Trajan Holdings LLC ("Trajan"). Series XVI AGH holds such shares and the AGH Warrants, discussed below, directly. Series XVI AGH owns no shares of the Issuer that are held by Trajan, directly or indirectly, and disclaims beneficial ownership interest in such shares. American Ventures IM LLC is the investment manager of Series XVI AGH and does not hold any shares or AGH Warrants directly. The number of shares represented by the amount in Rows 8, 10 and 11 excludes (i) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants A ("Common Warrants A"), (ii) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants B ("Common Warrants B"), and (iii) 29,030,677 shares of common stock that may be purchased by exercising the Issuer's Pre-Funded Common Stock Purchase Warrants ("Pre-Funded Warrants"), none of which are currently exercisable within 60 days (collectively, the "AGH Warrants"). However, pursuant to the warrant agreements relating to the AGH Warrants, the AGH Warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein Series XVI AGH may not exercise its AGH Warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XVI AGH together with its affiliates, and any other persons acting as a group together with Series XVI AGH or any of the Series XVI AGH's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XVI AGH, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of calculating the blockers, the number of shares of common stock beneficially owned by Series XVI AGH and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the AGH Warrants with respect to which such determination is being made, but will exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such warrant beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker pursuant to Rule 13d-3(d)(1)(i). The percent of class represented by the amount in Row 13 is based on 14,608,988 shares of the Issuer's common stock issued and outstanding as of August 14, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on August 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares represented by the amount in Rows 8, 10 and 11 includes (i) 0 shares of the Issuer's common stock owned by American Ventures LLC, Series XVI AGH ("Series XVI AGH") and (ii) 400,000 shares of the Issuer's common stock owned by Trajan Holdings LLC ("Trajan"). Series XVI AGH holds such shares and the AGH Warrants, discussed below, directly. Series XVI AGH owns no shares of the Issuer that are held by Trajan, directly or indirectly, and disclaims beneficial ownership interest in such shares. Dominari Holdings Inc. ("DOMH"), a Delaware corporation, is the majority member of American Ventures Management LLC and American Ventures IM LLC and does not hold any shares or the AGH Warrants directly. The number of shares represented by the amount in Rows 8, 10 and 11 excludes (i) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants A ("Common Warrants A"), (ii) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants B ("Common Warrants B"), and (iii) 29,030,677 shares of common stock that may be purchased by exercising the Issuer's Pre-Funded Common Stock Purchase Warrants ("Pre-Funded Warrants"), none of which are currently exercisable within 60 days (collectively, the "AGH Warrants"). However, pursuant to the warrant agreements relating to the AGH Warrants, the AGH Warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein Series XVI AGH may not exercise its AGH Warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XVI AGH together with its affiliates, and any other persons acting as a group together with Series XVI AGH or any of the Series XVI AGH's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XVI AGH, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of calculating the blockers, the number of shares of common stock beneficially owned by Series XVI AGH and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the AGH Warrants with respect to which such determination is being made, but will exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such warrant beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker pursuant to Rule 13d-3(d)(1)(i). The percent of class represented by the amount in Row 13 is based on 14,608,988 shares of the Issuer's common stock issued and outstanding as of August 14, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on August 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares represented by the amount in Rows 8, 10 and 11 includes (i) 0 shares of the Issuer's common stock owned by American Ventures LLC, Series XVI AGH ("Series XVI AGH") and (ii) 400,000 shares of the Issuer's common stock owned by Trajan Holdings LLC ("Trajan"). Series XVI AGH holds such shares and the AGH Warrants, discussed below, directly. Series XVI AGH owns no shares of the Issuer that are held by Trajan, directly or indirectly, and disclaims beneficial ownership interest in such shares. Eric Newman ("Mr. Newman") is the manager of American Ventures Management LLC and American Ventures IM LLC, respectively, which is the manager and investment manager of Series XVI AGH. Mr. Newman does not own any shares or AGH Warrants directly and disclaims beneficial ownership over any securities held by Series XVI AGH and Trajan other than to the extent of his respective pecuniary interest therein, directly or indirectly. The number of shares represented by the amount in Rows 8, 10 and 11 excludes (i) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants A ("Common Warrants A"), (ii) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants B ("Common Warrants B"), and (iii) 29,030,677 shares of common stock that may be purchased by exercising the Issuer's Pre-Funded Common Stock Purchase Warrants ("Pre-Funded Warrants"), none of which are currently exercisable within 60 days (collectively, the "AGH Warrants"). However, pursuant to the warrant agreements relating to the AGH Warrants, the AGH Warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein Series XVI AGH may not exercise its AGH Warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XVI AGH together with its affiliates, and any other persons acting as a group together with Series XVI AGH or any of the Series XVI AGH's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XVI AGH, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of calculating the blockers, the number of shares of common stock beneficially owned by Series XVI AGH and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the AGH Warrants with respect to which such determination is being made, but will exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such warrant beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker pursuant to Rule 13d-3(d)(1)(i). The percent of class represented by the amount in Row 13 is based on 14,608,988 shares of the Issuer's common stock issued and outstanding as of August 14, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on August 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares represented by the amount in Rows 8, 10 and 11 includes (i) 0 shares of the Issuer's common stock owned by American Ventures LLC, Series XVI AGH ("Series XVI AGH") and (ii) 400,000 shares of the Issuer's common stock owned by Trajan Holdings LLC ("Trajan"). Series XVI AGH holds such shares and the AGH Warrants, discussed below, directly. Series XVI AGH owns no shares of the Issuer that are held by Trajan, directly or indirectly, and disclaims beneficial ownership interest in such shares. Anthony Hayes ("Mr. Hayes") is the Chief Executive Officer, a director and Chairman of the board of directors of Dominari Holdings Inc., the majority member of American Ventures Management LLC and American Ventures IM LLC, respectively the manager and investment manager of Series XVI AGH. Mr. Hayes does not own any shares or AGH Warrants directly and disclaims beneficial ownership over any securities held by Series XVI AGH and Trajan other than to the extent of his respective pecuniary interest therein, directly or indirectly. The number of shares represented by the amount in Rows 8, 10 and 11 excludes (i) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants A ("Common Warrants A"), (ii) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants B ("Common Warrants B"), and (iii) 29,030,677 shares of common stock that may be purchased by exercising the Issuer's Pre-Funded Common Stock Purchase Warrants ("Pre-Funded Warrants"), none of which are currently exercisable within 60 days (collectively, the "AGH Warrants"). However, pursuant to the warrant agreements relating to the AGH Warrants, the AGH Warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein Series XVI AGH may not exercise its AGH Warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XVI AGH together with its affiliates, and any other persons acting as a group together with Series XVI AGH or any of the Series XVI AGH's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XVI AGH, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of calculating the blockers, the number of shares of common stock beneficially owned by Series XVI AGH and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the AGH Warrants with respect to which such determination is being made, but will exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such warrant beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker pursuant to Rule 13d-3(d)(1)(i). The percent of class represented by the amount in Row 13 is based on 14,608,988 shares of the Issuer's common stock issued and outstanding as of August 14, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on August 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares represented by the amount in Rows 8, 10 and 11 includes (i) 0 shares of the Issuer's common stock owned by American Ventures LLC, Series XVI AGH ("Series XVI AGH") and (ii) 400,000 shares of the Issuer's common stock owned by Trajan Holdings LLC ("Trajan"). Series XVI AGH holds such shares and the AGH Warrants, discussed below, directly. Series XVI AGH owns no shares of the Issuer that are held by Trajan, directly or indirectly, and disclaims beneficial ownership interest in such shares. Trajan owns no shares of the Issuer or AGH Warrants that are held by Series XVI AGH, directly or indirectly, and disclaims beneficial ownership interest in such shares and AGH Warrants. The number of shares represented by the amount in Rows 8, 10 and 11 excludes (i) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants A ("Common Warrants A"), (ii) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants B ("Common Warrants B"), and (iii) 29,030,677 shares of common stock that may be purchased by exercising the Issuer's Pre-Funded Common Stock Purchase Warrants ("Pre-Funded Warrants"), none of which are currently exercisable within 60 days (collectively, the "AGH Warrants"). However, pursuant to the warrant agreements relating to the AGH Warrants, the AGH Warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein Series XVI AGH may not exercise its AGH Warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XVI AGH together with its affiliates, and any other persons acting as a group together with Series XVI AGH or any of the Series XVI AGH's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XVI AGH, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of calculating the blockers, the number of shares of common stock beneficially owned by Series XVI AGH and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the AGH Warrants with respect to which such determination is being made, but will exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such warrant beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker pursuant to Rule 13d-3(d)(1)(i). The percent of class represented by the amount in Row 13 is based on 14,608,988 shares of the Issuer's common stock issued and outstanding as of August 14, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on August 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares represented by the amount in Rows 8, 10 and 11 includes (i) 0 shares of the Issuer's common stock owned by American Ventures LLC, Series XVI AGH ("Series XVI AGH") and (ii) 400,000 shares of the Issuer's common stock owned by Trajan Holdings LLC ("Trajan"). Series XVI AGH holds such shares and the AGH Warrants, discussed below, directly. Series XVI AGH owns no shares of the Issuer that are held by Trajan, directly or indirectly, and disclaims beneficial ownership interest in such shares. Kyle Wool ("Mr. Wool") is the sole member and manager of Trajan and thus has sole voting power and dispositive power over the securities of the Issuer held by Trajan. Additionally, Mr. Wool is the President of Dominari Holdings Inc., the majority member of American Ventures Management LLC and American Ventures IM LLC, respectively the manager and investment manager of Series XVI AGH. Mr. Wool does not own any shares or AGH Warrants directly and disclaims beneficial ownership over any securities held by Trajan and Series XVI AGH other than to the extent of his respective pecuniary interest therein, directly or indirectly. The number of shares represented by the amount in Rows 8, 10 and 11 excludes (i) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants A ("Common Warrants A"), (ii) 29,885,057 shares of common stock that may be purchased by exercising the Issuer's Common Stock Purchase Warrants B ("Common Warrants B"), and (iii) 29,030,677 shares of common stock that may be purchased by exercising the Issuer's Pre-Funded Common Stock Purchase Warrants ("Pre-Funded Warrants"), none of which are currently exercisable within 60 days (collectively, the "AGH Warrants"). However, pursuant to the warrant agreements relating to the AGH Warrants, the AGH Warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein Series XVI AGH may not exercise its AGH Warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XVI AGH together with its affiliates, and any other persons acting as a group together with Series XVI AGH or any of the Series XVI AGH's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XVI AGH, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of calculating the blockers, the number of shares of common stock beneficially owned by Series XVI AGH and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the AGH Warrants with respect to which such determination is being made, but will exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such warrant beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XVI AGH or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker pursuant to Rule 13d-3(d)(1)(i). The percent of class represented by the amount in Row 13 is based on 14,608,988 shares of the Issuer's common stock issued and outstanding as of August 14, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on August 14, 2025.


SCHEDULE 13D


American Ventures LLC, Series XVI AGH
Signature:/s/ Eric Newman
Name/Title:Eric Newman / Manager of American Ventures Management LLC, Manager of American Ventures LLC, Series XVI AGH
Date:09/30/2025
American Ventures Management LLC
Signature:/s/ Eric Newman
Name/Title:Eric Newman / Manager
Date:09/30/2025
American Ventures IM LLC
Signature:/s/ Eric Newman
Name/Title:Eric Newman / Manager
Date:09/30/2025
Dominari Holdings Inc.
Signature:/s/ Kyle Michael Wool
Name/Title:Kyle Michael Wool / President
Date:09/30/2025
Eric Newman
Signature:/s/ Eric Newman
Name/Title:Eric Newman / Self
Date:09/30/2025
Anthony Hayes
Signature:/s/ Anthony Hayes
Name/Title:Anthony Hayes / Self
Date:09/30/2025
Trajan Holdings LLC
Signature:/s/ Kyle Michael Wool
Name/Title:Kyle Michael Wool / Sole Member and Manager of Trajan Holdings LLC
Date:09/30/2025
Kyle Michael Wool
Signature:/s/ Kyle Michael Wool
Name/Title:Kyle Michael Wool / Self
Date:09/30/2025

FAQ

How many AGH shares does the reporting group currently own?

The reporting group discloses ownership of 400,000 shares, representing 2.74% of AGH's 14,608,988 outstanding shares as of August 14, 2025.

What warrants does the reporting group hold for AGH?

Series XVI AGH holds AGH Warrants comprising 29,885,057 Common Warrants A, 29,885,057 Common Warrants B, and 29,030,677 Pre-Funded Warrants, totaling 88,800,791 potential shares, none exercisable within 60 days per the filing.

Did the reporting group trade AGH shares recently?

Yes. In September 2025 Series XVI AGH exercised Pre-Funded Warrants for 125,392 shares and sold multiple lots on September 16–29, 2025, which collectively reduced the group’s beneficial ownership below 5%.

Are there ownership limits on exercising the AGH warrants?

Yes. The AGH Warrant agreements include 4.99% blockers or, at the holder’s election, 9.99% beneficial ownership limits that restrict exercise to avoid exceeding those thresholds.

What is the stated purpose for the acquisition of these securities?

The reporting persons state the securities were acquired for investment purposes and note they may engage in discussions regarding potential strategic transactions, but no definitive agreements are reported.
Aureus Greenway Holdings Inc.

NASDAQ:AGH

AGH Rankings

AGH Latest News

AGH Latest SEC Filings

AGH Stock Data

47.63M
7.59M
58.25%
1.54%
0.74%
Leisure
Services-membership Sports & Recreation Clubs
Link
United States
KISSIMMEE